Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 2,534 shares of the company's stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total value of $122,417.54. Following the sale, the chief financial officer now directly owns 3,545 shares in the company, valued at approximately $171,258.95. This represents a 41.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Fawwad Qureshi also recently made the following trade(s):
- On Tuesday, May 27th, Fawwad Qureshi sold 828 shares of Trupanion stock. The shares were sold at an average price of $45.53, for a total value of $37,698.84.
Trupanion Stock Performance
NASDAQ TRUP traded up $1.88 during trading hours on Friday, hitting $49.46. The company had a trading volume of 363,283 shares, compared to its average volume of 610,959. Trupanion, Inc. has a fifty-two week low of $25.90 and a fifty-two week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The business has a fifty day simple moving average of $40.75 and a 200-day simple moving average of $43.80. The firm has a market cap of $2.12 billion, a P/E ratio of -215.04, a price-to-earnings-growth ratio of 6.02 and a beta of 1.81.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same period last year, the company earned ($0.16) earnings per share. The firm's revenue for the quarter was up 11.7% on a year-over-year basis. Equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Inspire Investing LLC grew its stake in shares of Trupanion by 11.3% in the first quarter. Inspire Investing LLC now owns 9,292 shares of the financial services provider's stock worth $346,000 after purchasing an additional 940 shares in the last quarter. Bayforest Capital Ltd grew its stake in shares of Trupanion by 627.4% in the first quarter. Bayforest Capital Ltd now owns 28,457 shares of the financial services provider's stock worth $1,061,000 after purchasing an additional 24,545 shares in the last quarter. Millennium Management LLC grew its stake in shares of Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider's stock worth $9,987,000 after purchasing an additional 113,490 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider's stock worth $731,000 after purchasing an additional 858 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its stake in shares of Trupanion by 2,029.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 303,550 shares of the financial services provider's stock worth $11,313,000 after purchasing an additional 289,292 shares in the last quarter.
Analyst Ratings Changes
Several research firms recently issued reports on TRUP. Stifel Nicolaus dropped their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Piper Sandler dropped their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Finally, Lake Street Capital dropped their target price on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $51.80.
View Our Latest Analysis on Trupanion
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.